Transitional Drugs 4
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £4,090,814 (£4,908,977 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Wales |
| Deadline | 6 Aug 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-054590 |
Awards (3)
This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £4,090,814.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Amarox Pharma shared | £137,717 | 4 Sept 2025 | active |
| Novartis shared | £137,717 | 4 Sept 2025 | active |
| Novumgen Ltd shared | £137,717 | 4 Sept 2025 | active |
description
This contract is for the provision of Transitional Drugs 4 - namely Ticagrelor and Eltrombopag
documents
- https://www.find-tender.service.gov.uk/Notice/038016-2025 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 9 Jun 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 031042-2025 |
| 7 Jul 2025 | Tender notice (UK4) | Procurement Act 2023 | 038016-2025 |
| 5 Sept 2025 | Contract award (UK6) | Procurement Act 2023 | 054359-2025 |
| 25 Oct 2025 | Contract details (UK7) | Procurement Act 2023 | 068369-2025 |
more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- All Wales Dressings IV & Medical Tapes Tender · £1,940,212 · 23 Jul 2026
- EPQMS PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM · 16 Jul 2026
- Procurement of a Band 5 Locum Executive Assistant · 2 Jul 2026
- Procurement of a Band 5 Locum Business Support Officer · 2 Jul 2026
- Low and Mid Tech Medicines Homecare Services · £6,343,752 · 2 Jul 2026
- Provision of a Diploma in Healthcare Planning for NHS Wales · £2,426,900 · 2 Jul 2026
- Transitional Drugs 7 · £53,566,932 · 30 Jun 2026
- EICR testing at IP5 · £25,000 · 24 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.